MaXtremeZEN capsules, 1 capsule per blister pack, Distributed by: P&A Enterprise, Buena Park, CA 90621, UPC 6 10079 52468 2.
Published February 5, 2014 · Recall initiated: November 18, 2013
Summary
FDA records drug Class I recall D-1046-2014, published February 5, 2014 and initiated November 18, 2013. Recalling firm: SS Wholesale Inc. dba Jobbers Wholesale; Status: Terminated; Reported quantity: 2,395 blister packs total for all products; Lot: Lot #: JBP-L-1270-70, Exp 12/16. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without An Approved NDA/ANDA: FDA analysis found MaXtremeZEN which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine. Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug. Dapoxetine is an active ingredient not approved
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- SS Wholesale Inc. dba Jobbers Wholesale
- Distributor
- CA
- Lot
- Lot #: JBP-L-1270-70, Exp 12/16
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAeXtenZone capsules, 1 capsule per blister pack, Distributed by: P.M.C. Company, Buena Park, CA 90621, UPC 6February 5, 2014
- FDARhino 5 capsules(Spanish & English Labeling), 1 capsule per blister pack, Distributed by P&A Enterprise, BuenaFebruary 5, 2014
- FDAKETOCONAZOLE CREAM, 2%, 30 gram tube, Rx only, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc.,February 5, 2014
- FDAMercuroclear Antiseptic Anesthetic First Aid Helps prevent infection and relieves pain and itching of minorFebruary 5, 2014
- FDABuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b)February 5, 2014
- FDASoliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mLFebruary 5, 2014
Questions about this recall
Was MaXtremeZEN capsules, 1 capsule per blister pack, Distributed by: P&A Enterprise, Buena Park, CA 90621, UPC 6 10079 52468 2. recalled?
Yes. FDA published recall D-1046-2014 on February 5, 2014. Reported hazard: Marketed Without An Approved NDA/ANDA: FDA analysis found MaXtremeZEN which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine. Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug. Dapoxetine is an active ingredient not approved
What should I do if I have this product?
Voluntary: Firm initiated · Press Release